CancerNetwork®· @CancerNetwrk · X·· 13 小时前评分70
正文 · 原文
Full INTerpath-001 data at ESMO 2026 detail OS, subgroup, and safety results with intismeran plus pembrolizumab in resected stage IIB to IV melanoma. #melanoma #ESMO26 | @myESMO @ProfGLongMIA
https://www.cancernetwork.com/view/interpath-001-data-detail-survival-subgroup-and-safety-findings-in-melanoma
75 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA1按 Presidential Symposium I 对上
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgINTerpath-001
https://esmocongress.esmo.org来源：CancerNetwork® · x.com